Search Results for: Aurora
Aurora Cannabis to Host Second Quarter Fiscal Year 2022 Investor Conference Call on Feb. 10
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the…
Aurora Cannabis Delivers ~$10 Million Shipment of Medical Cannabis to Israel
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the…
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) (“Aurora”), the Canadian company defining the future of cannabinoids worldwide,…
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
Aurora Cannabis Inc. (NASDAQ | TSX: ACB) (“Aurora”), the Canadian company defining the future of…
Aurora Builds on a Decade of Global Leadership in Plant Genetics with the Launch of Occo
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the…
Aurora Cannabis Announces Fiscal 2022 First Quarter Results
Transformation Plan On Track; Actions Taken-to-Date Have Driven Over $33 Million in Annualized Run-Rate Cost Savings Total…
Aurora Cannabis Acquires a Significant Equity Stake in Growery B.V., One of 10 Successful Applicants for a Cannabis Production Licence in the Netherlands
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ | TSX: ACB), the Canadian company defining…
Aurora Cannabis to Host First Quarter Fiscal Year 2022 Investor Conference Call on Nov. 9
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining…
Aurora Cannabis Launches its First Medical CBD Product in Uruguay
Aurora Cannabis Inc. (NASDAQ | TSX: ACB), the Canadian company defining the future of cannabinoids…
Aurora Cannabis Announces Fiscal 2021 Fourth Quarter Results
#1 Canadian LP in Global Medical Cannabis; Total Medical Cannabis Net Revenue Rose 9% Compared…
Recent Comments